Related references
Note: Only part of the references are listed.Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure?
Ruben P. A. van Eijk et al.
PHARMACOGENOMICS JOURNAL (2020)
UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis
Katerina Placek et al.
NEUROBIOLOGY OF AGING (2019)
Unc13: a multifunctional synaptic marvel
Jeremy S Dittman
CURRENT OPINION IN NEUROBIOLOGY (2019)
Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen
Leonhard A. Bakker et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2019)
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
Henk-Jan Westeneng et al.
LANCET NEUROLOGY (2018)
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
Aude Nicolas et al.
NEURON (2018)
The multistep hypothesis of ALS revisited The role of genetic mutations
Adriano Chio et al.
NEUROLOGY (2018)
Rethinking Amyotrophic Lateral Sclerosis
Jeffrey Rosenfeld
MAYO CLINIC PROCEEDINGS (2018)
Amyotrophic lateral sclerosis
Michael A. van Es et al.
LANCET (2017)
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials
Ruben P. A. van Eijk et al.
NEUROLOGY (2017)
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
Michael J. Strong et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)
The cognitive profile of ALS: a systematic review and meta-analysis update
Emma Beeldman et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis
Daichi Yokoi et al.
JOURNAL OF NEUROLOGY (2016)
Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion
Henk-Jan Westeneng et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
Wouter van Rheenen et al.
NATURE GENETICS (2016)
UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort
Jose Manuel Vidal-Taboada et al.
JOURNAL OF NEUROLOGY (2015)
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy
Anna Montuschi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
C9orf72 and UNC13A Are Shared Risk Loci for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: A Genome-Wide Meta-Analysis
Frank P. Diekstra et al.
ANNALS OF NEUROLOGY (2014)
Correlation Between Structural and Functional Connectivity Impairment in Amyotrophic Lateral Sclerosis
Ruben Schmidt et al.
HUMAN BRAIN MAPPING (2014)
Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
Hiroshi Mitsumoto et al.
LANCET NEUROLOGY (2014)
GENETIC HETEROGENEITY OF AMYOTROPHIC LATERAL SCLEROSIS: IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH
Xiaowei W. Su et al.
MUSCLE & NERVE (2014)
Screening for cognition and behaviour changes in ALS
Sharon Abrahams et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Stages of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis
Johannes Brettschneider et al.
ANNALS OF NEUROLOGY (2013)
Amyotrophic lateral sclerosis-a model of corticofugal axonal spread
Heiko Braak et al.
NATURE REVIEWS NEUROLOGY (2013)
UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study
Adriano Chio et al.
NEUROBIOLOGY OF AGING (2013)
Multiparametric MRI study of ALS stratified for the C9orf72 genotype
Peter Bede et al.
NEUROLOGY (2013)
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72
Adriano Chio et al.
BRAIN (2012)
Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study (vol 11, pg 232, 2012)
S. Byrne et al.
LANCET NEUROLOGY (2012)
UNC13A is a modifier of survival in amyotrophic lateral sclerosis
Frank P. Diekstra et al.
NEUROBIOLOGY OF AGING (2012)
The ALS-FTD-Q A new screening tool for behavioral disturbances in ALS
Joost Raaphorst et al.
NEUROLOGY (2012)
Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases
Wouter van Rheenen et al.
NEUROLOGY (2012)
Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study
Susan Byrne et al.
LANCET NEUROLOGY (2012)
Network-based statistic: Identifying differences in brain networks
Andrew Zalesky et al.
NEUROIMAGE (2010)
Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study
Jennifer L. Whitwell et al.
BRAIN (2009)
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis
Michael A. van Es et al.
NATURE GENETICS (2009)
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
Rahul S. Desikan et al.
NEUROIMAGE (2006)
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
F Kimura et al.
NEUROLOGY (2006)